Focus Partners Wealth Grows Position in GE HealthCare Technologies Inc. $GEHC

Focus Partners Wealth lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 6.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 824,213 shares of the company’s stock after purchasing an additional 46,522 shares during the quarter. Focus Partners Wealth owned 0.18% of GE HealthCare Technologies worth $61,902,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in GEHC. E Fund Management Hong Kong Co. Ltd. boosted its holdings in GE HealthCare Technologies by 130.7% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after buying an additional 196 shares in the last quarter. Godsey & Gibb Inc. acquired a new stake in GE HealthCare Technologies during the third quarter valued at $26,000. Oakworth Capital Inc. increased its holdings in GE HealthCare Technologies by 1,876.2% in the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after buying an additional 394 shares in the last quarter. Piscataqua Savings Bank increased its holdings in GE HealthCare Technologies by 173.4% in the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock valued at $36,000 after buying an additional 300 shares in the last quarter. Finally, Salomon & Ludwin LLC raised its position in shares of GE HealthCare Technologies by 326.5% in the third quarter. Salomon & Ludwin LLC now owns 482 shares of the company’s stock worth $37,000 after acquiring an additional 369 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Up 2.0%

GEHC stock opened at $72.17 on Tuesday. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $89.77. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The firm has a 50-day simple moving average of $80.53 and a 200-day simple moving average of $78.53. The stock has a market capitalization of $32.89 billion, a P/E ratio of 15.83, a P/E/G ratio of 1.56 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. During the same period last year, the company posted $1.45 EPS. GE HealthCare Technologies’s quarterly revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on GEHC shares. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Evercore upped their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Wall Street Zen upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Finally, Stifel Nicolaus boosted their price objective on GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research report on Wednesday, February 4th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Hold” and an average target price of $92.17.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.